The current findings also suggest that self-injection might be driven by poor perception of primary care safety and especially low-perceived dignity and respect
Primary Metabolic Pathways Beta-3-Adrenergic Receptor Modulation Research in obese mice demonstrated that AOD-9604 increases expression of beta-3-adrenergic receptor RNA in adipose tissue, upregulating levels from those seen in obese animals to levels comparable with lean controls
In recent years, the therapeutic footprint of this class has grown: long-acting agents (e.g., liraglutide, semaglutide) and next-generation dual/triple agonists (e.g., tirzepatide) have demonstrated superior glycemic control, weight reduction, and cardiovascular benefits in adults with T2DM (Yao et al., 2024)
However, more research is needed to establish these effects conclusively
Consult your healthcare provider before making changes to your diet while taking GLP-1 medications
doi: 10.1038/ng585 31 MagreJPrieurX